Literature DB >> 3525851

Update in cancer chemotherapy: gastrointestinal cancer, cancer of the pancreas.

J C Wright.   

Abstract

An update of the state of the art of cancer chemotherapeutic treatment of gastrointestinal tract cancer is described in this multiple-part series. A review of cancers of the colon, rectum, and anus was published in the April and May issues of the Journal. In this section, cancer of the pancreas and its treatment with surgery, radiation therapy, chemotherapy, and adjuvant chemotherapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3525851      PMCID: PMC2571298     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  30 in total

Review 1.  The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.

Authors:  S K Carter; R L Comis
Journal:  Cancer Treat Rev       Date:  1975-09       Impact factor: 12.111

2.  Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.

Authors:  C G Moertel; H O Douglass; J Hanley; P P Carbone
Journal:  Cancer Treat Rep       Date:  1976-11

3.  Pancreatic islet cell carcinoma. II. Results of therapy with streptozotocin in 52 patients.

Authors:  L E Broder; S K Carter
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

4.  Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas.

Authors:  J B Haslam; P J Cavanaugh; S L Stroup
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

5.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

Authors:  C G Moertel; D S Childs; R J Reitemeier; M Y Colby; M A Holbrook
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

6.  Chemotherapy for carcinoma of the pancreas.

Authors:  W R Waddell
Journal:  Surgery       Date:  1973-09       Impact factor: 3.982

7.  Proceedings: A controlled study of combined 1,3-bis-(2-chloroethyl)-1-nitrosourea and 5-fluorouracil therapy for advanced gastric and pancreatic cancer.

Authors:  J S Kovach; C G Moertel; A J Schutt; R G Hahn; R J Reitemeier
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

Review 8.  Current status of chemotherapy for advanced pancreatic and gastric cancer.

Authors:  M J O'Connell
Journal:  J Clin Oncol       Date:  1985-07       Impact factor: 44.544

9.  Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy.

Authors:  J Tepper; G Nardi; H Sutt
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

10.  Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.

Authors:  J J Lokich; A T Skarin
Journal:  Cancer Chemother Rep       Date:  1972-10
View more
  1 in total

1.  Adjuvant/Perioperative Therapy in Pancreatic and Periampullary Cancer.

Authors:  Matthew J Reilley; Rachna Shroff; Gauri R Varadhachary
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.